Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6537241 | 1.00 | USP2 (0.32) | USP2ALOX15 | |
| SCHEMBL6537520 | 0.98 | USP2 (0.31) | USP2ALOX15 | |
| SCHEMBL6537518 | 0.81 | — | — | |
| SCHEMBL8633440 | 0.75 | GABRR1 (0.32) | — | |
| SCHEMBL10796364 | 0.70 | ALOX5 (0.35) | — | |
| SCHEMBL10796359 | 0.70 | ALOX5 (0.35) | — | |
| SCHEMBL7559996 | 0.67 | TDP1 (0.42) | ALOX15 | |
| SCHEMBL3212653 | 0.67 | TDP1 (0.42) | ALOX15 | |
| SCHEMBL9569514 | 0.64 | — | — | |
| SCHEMBL9569521 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6680308-B1 | ADMINISTERING N-(FORMYL OR ACETYL)-N-HYDROXYLAMINO)-ALKYLPHOSPHONIC ACID DERIVATIVE AS VIRICIDE, PARASITICIDE OR FUNGICIDE | BIOAGENCY AG (DE) | 2004-01-20 | — | — | US | claimed |
| US-4182758-A | BACTERICIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-01-08 | — | — | US | claimed |
| US-20250325569-A1 | COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2025-10-23 | — | — | US | disclosed |
| WO-2023200968-A1 | COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2023-10-19 | — | — | WO | disclosed |
| US-20200140469-A1 | NOVEL ALKENYL AND BETA-SUBSTITUTED PHROSPHONATES AS ANTIMICROBIAL AGENTS | THE GEORGE WASHINGTON UNIVERSITY (US) | 2020-05-07 | — | — | US | disclosed |
| WO-2019005982-A1 | NOVEL ALKENYL AND BETA-SUBSTITUTED PHOSPHONATES AS ANTIMICROBIAL AGENTS | THE GEORGE WASHINGTON UNIVERSITY (US) | 2019-01-03 | — | — | WO | disclosed |
| EP-1100510-A2 | COMBINED PREPARATION OF ANTI-INFECTIOUSLY ACTIVE COMPOUNDS WHICH INHIBIT THE 2-C-METHYLERYTHROSE-4 METABOLIC PATHWAY, AND INHIBITORS OF LIPID METABOLISM | Jomaa, Hassan (DE) | 2001-05-23 | — | — | EP | disclosed |
| WO-1999066875-A2 | COMBINED PREPARATION OF ANTI-INFECTIOUSLY ACTIVE COMPOUNDS WHICH INHIBIT THE 2-C-METHYLERYTHROSE-4 METABOLIC PATHWAY, AND INHIBITORS OF LIPID METABOLISM | JOMAA HASSAN (DE) | 1999-12-29 | — | — | WO | disclosed |
| US-4206156-A | ANTIMICROBIAL | FUJISAWA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1980-06-03 | — | — | US | disclosed |
| US-4182758-A | BACTERICIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200140469-A1 | NOVEL ALKENYL AND BETA-SUBSTITUTED PHROSPHONATES AS ANTIMICROBIAL AGENTS | FDPS, PGLS, G6PD | USP2 2390/4885ALOX15 639/4885 |
| US-20250325569-A1 | COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF | PGLS, PLA2G2C, PPA1 | USP2 3814/4885ALOX15 194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.